Reporting from AACR 2019 in Atlanta, C. Mackall explains the current strategies in developing next-generation CAR T cells capable of overcoming tumour resistance, and what challenges the scientists are facing in their efforts.
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.